Company
ARSYNL Rx
ARSYNL Rx publishes compounded tirzepatide at $256.33 a month — Tirzepatide HypoSpray (transdermal, needle-free).
Published by Treatment Registry · Latest research
- 1 program
- 1 identified molecule
- 1 reading
Read from arsynl.com; latest program check September 2026. Individual programs and sources may have earlier verification dates.
Go to ARSYNL Rx
We earn nothing from this link. It opens ARSYNL Rx's website without a paid referral.
What it costs
first month, including required fees on record · Tirzepatide HypoSpray (transdermal, needle-free)
Terms
- Pharmacy
The Pharmacy Hub; Chemistry Rx; Vital Rx; Optimal Balance Pharmacy; Center City Pharmacy; Olympia Pharmacy
Evidence: September 2026
Not yet checked: membership, consultation fee and states.
Programs
Notes
Pricing details, service terms and questions to confirm before enrolling.
September 2026
- 1. Tirzepatide is sold in two formats: a standard injectable at $233/mo and a needle-free transdermal 'HypoSpray' at $256.33/mo. The HypoSpray's delivery method (a metered transdermal spray) does not match any of the schema's form options (not an injection, oral tablet, or sublingual placement), so it was recorded as not-disclosed with this note. Neither injectable product page states vial vs. pen.
Understand the terms
- Understanding pharmacy disclosures
A named pharmacy or network does not establish who will fill your prescription.
- Cancellation and refunds
Ending future billing and refunding an existing order are separate questions.
Before you act
Cite this
Treatment Registry. (2026). ARSYNL Rx: recorded programs and prices. Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/arsynl-rx